Financial statements Milapharm
Balance sheet of Milapharm
Company age:
Age:
8 y. 1 m. 6 d.
Share capital:
Share capital:
100 000 PLN
Balance sheet data of MILAPHARM
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 321 984,28 | 328 601,35 | 1 969 538,39 | 12 367 983,76 | 15 769 911,04 | 22 071 030,93 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 | 1 012 000,00 | 5 066 333,86 | 12 191 230,21 |
| B. Current assets | 321 984,28 | 328 601,35 | 1 969 538,39 | 11 355 983,76 | 10 703 577,18 | 9 879 800,72 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | - | - | - |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | - | - | - |
| Total liabilities | 321 984,28 | 328 601,35 | 1 969 538,39 | 12 367 983,76 | 15 769 911,04 | 22 071 030,93 |
| A. Equity | 21 652,75 | 213 229,11 | 834 155,84 | 7 678 351,29 | 13 517 861,11 | 14 281 895,09 |
| B. Liabilities and provisions for liabilities | 300 331,53 | 115 372,24 | 1 135 382,55 | 4 689 632,47 | 2 252 049,93 | 7 789 135,84 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | - | - | - |
| II. Short-term liabilities | 300 331,53 | 115 372,24 | 1 135 382,55 | 4 689 632,47 | 2 252 049,93 | 7 789 135,84 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.